Albert Goday has received fees for investigation projects, consulting, and postgraduate training, and has participated in clinical trials sponsored by Almirall, Ascensia, Colegio de Farmacuticos de Barcelona, Esteve, Federacin Farmacutica, Fundacin Catalana Sndrome de Down, Fundaci Gol i Gorina, Instituto de Salud Carlos III, Jansen, Lilly, Menarini, MSD, Mutuam, Novo Nordisk, Pronokal, RedGDPS, Rovi, Sanofi Aventis
Many clinicians pause SGLT2i therapy during active foot ulceration, infection, osteomyelitis or gangrene
Consistent data collection makes protocol adjustments more informed and outcomes more meaningful
Medicinal herbs in the relief of neurological, cardiovascular, and respiratory symptoms after COVID-19 infection a literature review
Side effects are common in the first week of treatment as your body adjusts to the medication